 |
|
|
Ronald L. Dalman MD
Email:
Phone:(650) 723-2031 Profile: http://med.stanford.edu/profiles/Ronald_Dalman/
Alternate Contact: Academic Appointments
Appointment
Organization
Professor - Med Center Line
Member
|
Curriculum Vitae PDF
NIH Biosketch DocHonors & Awards
Title
Organization
Date(s)
Chairman, Membership Committee
Society for Vascular Surgery
2001
Member, Research Council
Society for Vascular Surgery
2004-2007
Ad hoc member, Biotechnology and Surgical Sciences Study Section
Center for Scientific Review, NIH
2003-2005
President, Silicon Valley Affiliate
American Heart Association
1999-2000
E. J. Wylie Travelling Fellowship in Vascular Surgery
Lifeline Foundation
2000 -2001
Administrative Appointments
Title
Organization
Start Year
End Year
Program Director, Vascular Surgery Residency Program
Stanford University School of Medicien
2005
-
Staff Surgeon, Vascular Surgery Section
Surgical Service, VAPAHCS
1991
-
Professor and Chief, Division of Vascular Surgery
Department of Surgery
2005
-
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
Fellowship
Texas Tech University
Endovascular Surgery
2003
Fellowship
Oregon Health Sciences Univ.
Vascular Surgery
1991
Surgical Residency
Univ. of Washington, Seattle
Surgery
1989
MD
.University of Michigan - Ann Arbor
.Medicine
1984
Postdoctoral Advisees
Noriyuki Miyama,
Janice Yeung
Web Site Links
Research/Lab website:
Vascular Division Webpage
Research Interests
We are investigating the way arteries enlarge and remodel in response to blood flow. We have investigated
this phenomenon in patients, canine, rat and mouse models of aortic aneurysm disease and peripheral vascular occlusive disease (PVOD). We use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.
By extension we are keenly interested in new surgical technology and its application to aneurysmal and
occlusive arterial and venous diseases. To this end we have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. We are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.
this phenomenon in patients, canine, rat and mouse models of aortic aneurysm disease and peripheral vascular occlusive disease (PVOD). We use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.
By extension we are keenly interested in new surgical technology and its application to aneurysmal and
occlusive arterial and venous diseases. To this end we have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. We are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.
Community and International Work
- See Biosketch, . More »
Publications
- Tedesco MM, Pak JJ, Harris EJ, Krummel TM, Dalman RL, Lee JT "Simulation-based endovascular skills assessment: The future of credentialing?" J Vasc Surg 2008; More »
- Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW "Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial." JAMA 2007; 297: 6: 603-10 More »
- Dalman RL, "Invited commentary." J Vasc Surg 2007; 46: 1: 15 More »
- Dalman RL, "Invited commentary." J Vasc Surg 2007; 46: 3: 440-1 More »
- Tedesco MM, Lee JT, Dalman RL, Lane B, Loh C, Haukoos JS, Rapp JH, Coogan SM "Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting." J Vasc Surg 2007; 46: 2: 244-50 More »
42 publications: view full list
